ELV Elevance Health, Inc. Common Stock

NYSE · Health Care · Visualizza su SEC EDGAR ↗
$400,48
Prezzo · Ago 19, 2026
Fondamentali al Lug 15, 2026

Informazioni su Elevance Health, Inc. Common Stock Panoramica della società da Wikipedia

Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans.

Leggi di più

Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans.

Based on its 2021 revenues, the company ranked 20th on the 2022 Fortune 500. In 2023, the company's seat in Forbes Global 2000 rankings was 78. Carelon Global Solutions, Elevance Health's Business Process Outsourcing (BPO)/Shared Services subsidiary, serves the group's offshore and customer service management. It operates sites in India, Puerto Rico, Philippines, and the United States.

History

Anthem

In 1946, Anthem began in Indianapolis, Indiana, as Mutual Hospital Insurance Inc. and Mutual Medical Insurance Inc. The companies grew significantly, controlling 80% of the medical insurance market in Indiana by the 1970s.

In 1972, the two firms, then known as Blue Cross of Indiana and Blue Shield of Indiana, entered into a joint operating agreement.

In 1985, the two companies merged into Associated Insurance Companies, Inc,, later called, The Associated Group, a holding company, but usage of the name "Anthem" persisted. In 1989, the company purchased American General Insurance Co. for $150 million and in 1991, it acquired The Shelby Insurance Co., based in Shelby, Ohio, for $125 million. In 1989, The Associated Group founded Acordia, a brokerage that sold and serviced insurance and employee benefit programs.

In 1993, Acordia acquired American Business Insurance for $130 million and the Federal Kemper Insurance Company for $100 million. The Associated Group merged with Southeastern Mutual Insurance Company, the operator of Blue Cross and Blue Shield of Kentucky. In 1994, it sold Raffensperger, Hughes & Co., Inc., Indiana's largest investment bank, to National City Corp.

In 1995, The Associated Group acquired Community Mutual Insurance, a provider of Blue Cross and Blue Shield insurance plans in Ohio with over 1.9 million policy holders), then set up Anthem Blue Cross and Blue Shield. In 1996, The Associated Group changed its name to Anthem Insurance Company. In August 1997, Anthem acquired Blue Cross and Blue Shield of Connecticut. It also sold Acordia to management.

In 1999, Anthem acquired Blue Cross and Blue Shield of New Hampshire and Blue Cross and Blue Shield of Colorado and Nevada, using debt financing. The acquisitions made since 1996 added 850,000 policy holders. Among its customer base were 2.4 million PPO and 964,000 HMO enrollees.

In 2000, Anthem acquired Blue Cross Blue Shield of Maine. The Gramm-Leach-Bliley Act of 1999 made it possible for Anthem to undergo demutualization and become a public company via an initial public offering, which made it the fourth largest public managed health care company in the United States.

In 2002, Anthem acquired Trigon Healthcare of Virginia, a Blue Cross and Blue Shield plan, the largest insurer in Virginia, for $4.04 billion. Anthem Insurance Company reached 11.9 million members.

Blue Cross of California

Blue Cross of California was the predecessor of WellPoint Health Network Inc.

In 1982, Blue Cross of California was founded with the consolidation of Blue Cross of Northern California (established in 1936) and Blue Cross of Southern California (established in 1937).

In 1992, WellPoint was formed to operate Blue Cross of California's managed care business. In January 1993, Blue Cross of California spun off its managed care business into a publicly traded entity, WellPoint Health Networks Inc. Blue Cross of California retained an 80% interest and voting control.

In 1996, Blue Cross of California restructured to a for-profit corporation, designating WellPoint Health Networks Inc. as the parent organization. In April 1996, WellPoint completed its acquisition of Massachusetts Mutual Life Insurance Company's group life and health insurance subsidiaries for approximately $380 million, making it the second largest publicly held managed health company in the U.S. with 4 million policyholders.

In March 1997, WellPoint acquired the group health and life businesses of John Hancock Financial for $86.7 million. With this acquisition, WellPoint expanded its presence into Michigan, Texas, and the mid-Atlantic, and gained a unit that concentrated on serving the needs of large employers.

In 2000, WellPoint acquired PrecisionRx, a mail service pharmacy fulfillment center in Texas. In March 2000, WellPoint acquired Rush Prudential Health Plans, a Chicago provider, for $204 million. In March 2001, WellPoint acquired Cerulean Companies, the parent company of Blue Cross Blue Shield of Georgia. In 2001, WellPoint offered to acquire CareFirst BlueCross BlueShield for $1.37 billion, including $119 million in bonuses to Carefirst executives. In 2003, the offer was rejected by the Maryland insurance commissioner.

In 2002, WellPoint acquired RightChoice Managed Care, a Missouri-based company that ran Blue Cross and Blue Shield for part of the state, for $1.5 billion. RightChoice also owned provider network company HealthLink. WellPoint also acquired MethodistCare of Houston, Texas and HealthLink. In 2003, WellPoint acquired Golden West Dental and Vision of Camarillo, California, and Cobalt, including Blue Cross and Blue Shield United of Wisconsin.

In November 2004, Wellpoint, Inc. was formed by the merger of Anthem Insurance Company and WellPoint Health Networks Inc. The merger was structured as Anthem acquiring WellPoint Health Networks and renaming itself WellPoint, Inc. WellPoint continued to use 'Anthem' as the brand name under which it operated. It sold its Blue Cross and Blue Shield products in 11 states.

In 2005, WellPoint acquired Alexandria, Virginia–based Lumenos, a provider of consumer-driven health care, for $185 million. Lumenos was the pioneer and market leader in consumer-driven health plans. In December, WellPoint acquired WellChoice, a New York City-based Blue Cross Blue Shield provider, for approximately $6.5 billion, making New York the 14th state in which WellPoint is a Blue Cross Blue Shield licensee.

In 2007, WellPoint acquired Chicago-based American Imaging Management, a radiology benefit management company that creates software to help physicians choose cost-effective locations for their patients to receive medical imaging tests. WellPoint also acquired Chicago-based American Imaging Management (AIM), the leading radiology benefit management company.

In January 2008, Leslie Margolin became the president of California operations. She resigned in July 2010. In 2008, WellPoint acquired Resolution Health, a firm that analyzes patient history for potential medical problems such as adverse drug interactions. In 2009, WellPoint acquired DeCare Dental, a dental insurance firm.

In 2011, WellPoint acquired CareMore, a Cerritos, California-based provider of insurance and care centers for elderly patients. In 2012, WellPoint acquired Amerigroup for $4.9 billion, anticipating significant growth due to Medicaid expansion under the Patient Protection and Affordable Care Act. In August 2012, CEO Angela Braly resigned due to pressure from investors.

On August 13, 2014, WellPoint announced it intended to change its name to Anthem, Inc., effective in December.

Anthem, Inc.

In February 2015, the company acquired Simply Healthcare Holdings, a Medicaid and Medicare managed care company based in Florida. In June 2015, Anthem made an offer to acquire Cigna for more than $54 billion in cash and stock. In February 2017, United States district court Judge Amy Berman Jackson blocked the Cigna merger on grounds of anti-competitive practices. On February 14, Cigna called off its merger agreement with Anthem.

In October 2017, Anthem announced that it would not renew its pharmacy benefit management (PBM) relationship with Express Scripts saying it had been overcharged $3 billion and that instead, Anthem would eventually handle the PBM process itself through its new IngenioRx unit. Anthem announced that it would enter a 5-year contract with CVS Health. Cigna then announced plans in March 2018 to acquire Express Scripts for $58 billion. On November 6, 2017, Gail Koziara Boudreaux was named CEO. In 2018, the company announced a $20 million expansion of its headquarters and the signing of a lease in Atlanta for its technology center. In March 2020, Anthem announced the acquisition of Beacon Health Options, and independently held behavioral health organization.

On February 2, 2021, Anthem announced the acquisition of InnovaCare Health's Puerto Rico subsidiaries including MMM Holdings, LLC ("MMM") and its Medicare Advantage (MA) plan MMM Healthcare, LLC as well as affiliated companies and Medicaid plan. In November 2021, Anthem announced the acquisition of Integra Managed Care in New York. The acquisition of the New York-based international health insurance company was completed on May 5, 2022.

On June 28, 2022, Anthem announced a change of its corporate name to Elevance Health, Inc. and also changed its stock ticker symbol from "ANTM" to "ELV".

Elevance Health

On January 23, 2023, Elevance announced that it entered a definitive agreement to acquire Blue Cross and Blue Shield of Louisiana, increasing Elevance's footprint to 15 states and adding 1.9 million new members. In 2023, Elevance announced that it would rebrand its Amerigroup business as Wellpoint starting in 2024.

As of 2025, Elevance subsidiaries Carelon Behavioral Health and Anthem Blue Cross and Blue Shield are the subject of three lawsuits in New York and Connecticut alleging that they operate ghost networks.

Subsidiaries

Elevance Health includes the following subsidiaries:

Amerigroup

District of Columbia (Medicaid)

Georgia (Medicaid)

New Mexico (Medicare Advantage)

Anthem Blue Cross

California

Blue Cross of California Partnership Plan (Medicaid)

New York (upstate)

Anthem Blue Cross Blue Shield

Colorado

Connecticut

Georgia

Indiana (includes Medicaid)

Kentucky

Anthem Blue Cross and Blue Shield Medicaid

Maine

Missouri (excluding 30 counties in the Kansas City area)

Nevada

Anthem Blue Cross and Blue Shield Healthcare Solutions (Medicaid)

New Hampshire

New York (downstate)

HealthPlus (Medicaid)

Ohio

Virginia (excluding Alexandria City, Arlington County, Falls Church City, and parts of Fairfax County)

HealthKeepers (Medicaid)

Wisconsin

Carelon Behavioral Health

Carelon Behavioral Health of California

Carelon Behavioral Health of Kansas

Carelon Health of Pennsylvania

Carelon Global Solutions (Business Process Outsourcing/Shared Services)

Freedom Health

Florida

Golden West Dental & Vision

California

HealthSun

Florida

MMM

Puerto Rico

Optimum Healthcare

Florida

Simply Healthcare

Florida

UniCare

West Virginia

WellPoint

Arizona (Medicare Advantage)

Iowa (Medicaid and Medicare Advantage)

Maryland (Medicaid)

Massachusetts (government employees)

New Jersey (Medicaid and Medicare Advantage)

Tennessee (Medicaid and Medicare Advantage)

Texas (Medicaid and Medicare Advantage)

Washington (Medicaid and Medicare Advantage)

Joint ventures

Elevance Health operates joint ventures including:

Anthem | MaineHealth (with MaineHealth)

Maine

Blue Medicare Advantage (with Independence Blue Cross)

Pennsylvania

Colorado Community Health Alliance (with Centura Health, Physician Health Partners and Primary Physician Partners)

Colorado

Healthy Blue Kansas (with Blue Cross and Blue Shield of Kansas and Blue Cross and Blue Shield of Kansas City)

Kansas

Healthy Blue Louisiana (with Blue Cross Blue Shield of Louisiana)

Louisiana

Summit Community Care

Arkansas

Centers Plan for Healthy Living

New York, Florida

Quality of care

In 2011, in the category of "Meeting National Standards of Care," California's state patient advocacy office gave Anthem a rating of 2 out of 4 stars. In 2014, it received 3 out of 4 stars in the same category. In 2022, twenty-one of Elevance Health's affiliated Medicaid plans earned accreditation for health equity from the National Committee for Quality Assurance (NCQA).

Controversies

Charitable donations

In 2007, WellPoint pledged to spend $30 million over three years, through the company's charitable foundation, to help the uninsured. In March 2010, the Los Angeles Times reported that WellPoint's tax records and website showed that the company had given only $6.2 million by 2009. The company said that the foundation had indeed fulfilled its $30-million commitment by mid-2009, but refused to provide any financial details to support its claim.

2007 DMHC investigation

In 2007, the California Department of Managed Health Care (DMHC) investigated Anthem's policies for revoking (rescinding) health care insurance policies. The DMHC randomly selected 90 instances where Anthem canceled the insurance of policy holders who had been diagnosed with costly or life-threatening illnesses, to find how many of these cancellations were legal. The agency concluded that all these cancellations were illegal.

In July 2008, Anthem Blue Cross agreed to a settlement with the California Department of Managed Health Care; however in doing so, WellPoint did not officially admit liability. To resolve allegations of improper policy rescissions (cancellations), WellPoint paid $10 million and reinstated plans for 1,770 policy-holders who were affected by cancelled policies. The company also agreed to provide compensation for any medical debts incurred by these policy-holders.

2010 Reuters exposé

In April 2010, Reuters alleged that Wellpoint "using a computer algorithm, identified women recently diagnosed with breast cancer and then singled them out for cancellation of their policies." The software used immediately triggered fraud investigation for those recently diagnosed with the disease as the company searched for some pretext to drop their policies. Wellpoint argued that its algorithm was scanning for diagnostic codes for conditions that patients might have known about during the insurance application. The story not only caused considerable public outrage, but it also led Secretary of Health and Human Services, Kathleen Sebelius, and President Barack Obama, to call on WellPoint to end the practice.

In 2011, Anthem began cancelling policies of members who had been paying premiums with credit cards, sometimes without calling or emailing the member ahead of time.

Opposition to healthcare reform

In August 2009, Anthem, the largest for-profit insurer in California, contacted its employees and urged them to get involved to oppose healthcare reforms proposed during the Obama administration. Consumer Watchdog, a nonprofit watchdog organization in Santa Monica, asked California Attorney General Jerry Brown to investigate its claim that WellPoint had illegally pushed workers to write to their elected officials, attend town hall meetings and enlist family and friends to ensure an overhaul that would match the firm's interests. According to Consumer Watchdog, California's labor code directly prohibits coercive communications, including forbidding employers from controlling, coercing or influencing employees' political activities or affiliations. WellPoint had not been contacted by the California attorney general and had not seen any complaint.

Through 2010 and into 2011, WellPoint senior executives met monthly with executives of other major health insurers to blunt the effect of the Patient Protection and Affordable Care Act.

Premium increases in Maine

In 2009, Anthem Health Plans of Maine, a WellPoint subsidiary, sued the state of Maine for the right to increase premiums further. Since Maine licenses insurance companies through its Bureau of Insurance, Anthem needed the state's permission to raise rates. The Court disagreed with Anthem and found that, unlike with other forms of insurance, the Maine Insurance Code does not require the Superintendent to consider profits.

Rate increases in California

In February 2010, WellPoint announced that rates would increase on some Anthem Blue Cross individual policies in California by as high as 39%. The announcement resulted in an investigation by regulators from the Federal and California governments. Anthem Blue Cross gained worldwide media attention and became a poster child for the problem of rising cost of health care in the U.S. The rate increase came one year after Anthem had raised rates 68% on individual policy holders.

To explain the rate increases, some which were four times the rate of medical inflation, Anthem said the company had experienced a death spiral: the company claimed that with increased unemployment and declining wages, healthy customers dropped their insurance policies. Consequently, the remaining risk pool became sicker and thus more expensive to insure; and, in turn, prices were forced up and pushed more people out of the market.

In response to the outrage from politicians and consumers, Anthem postponed the rate increase until May 1, 2010.

Senator Dianne Feinstein of California proposed giving the Federal government of the United States authority to block insurance premium hikes that it considers to be "unjustified".

WellPoint cost reclassification

On March 17, 2010, WellPoint announced it was reclassifying some of its administrative costs as medical care costs in order to meet loss ratio requirements under the Patient Protection and Affordable Care Act, which requires insurers to spend at least 80% or 85% of customer premiums on health care services, depending on the type of plan.

2009–2010 data breach

In June 2010, Anthem sent letters to 230,000 customers in California warning them that their personal data might have been accessed online via a data breach. After a routine upgrade in October 2009, a third-party vendor stated that all security measures had been properly reinstated, when in fact they had not. As a result, personal information of thousands of coverage applicants who were under the age of 65 was exposed in the open. After a Los Angeles-area woman found that her application for coverage was publicly available, she filed a class action lawsuit against Anthem. While gathering evidence for the proceeding, the woman's lawyers downloaded some confidential customer information from Anthem's website and alerted Anthem about the breach. According to the lawyers, confidential information had remained exposed for five months. Greg Zoeller, Indiana's Attorney General, filed a lawsuit against the company seeking $300,000 in civil penalties for the company alleged failure to notify its consumers about the breach.

Denial of benefits for cancer treatment

In May 2014, Anthem Blue Cross refused to pay for the hospitalization of a Sonoma County, California man for stage four cancers, although he had paid Anthem over $100,000 in premiums. Anthem ended up paying for coverage following public outcry.

2015 data breach

On February 4, 2015, Anthem, Inc. disclosed that criminal hackers had broken into its servers and potentially stolen over 37.5 million records that contain personally identifiable information from its servers. According to Anthem, Inc., the data breach extended into multiple brands Anthem, Inc. uses to market its healthcare plans, including, Anthem Blue Cross, Anthem Blue Cross and Blue Shield, Blue Cross and Blue Shield of Georgia, Empire Blue Cross and Blue Shield, Amerigroup, Caremore, and UniCare. Healthlink was also victimized. Anthem says the medical information and financial data was not compromised. Anthem has offered free credit monitoring in the wake of the breach. According to Bloomberg News, China may be responsible for this data breach. Michael Daniel, chief adviser on cybersecurity for President Barack Obama, said he would be changing his own password. About 80 million company records were hacked, stoking fears that the stolen data could be used for identity theft. The compromised information contained names, birthdays, medical IDs, social security numbers, street addresses, e-mail addresses, employment information and income data. In June 2017, Anthem agreed to spend $115M to settle allegations that it failed to adequately protect the data of its clients, the sum was to be spent on two years of services to protect victims from identity theft. In 2019, two Chinese nationals were indicted for the breach.

"Avoidable ER program"

Beginning in 2015, Anthem has been implementing and expanding its "avoidable ER program" which means not reimbursing ER visits when the cause is not covered by the company. A few patients found out that they had been stuck with bills of over $10,000 that Anthem refused to reimburse. According to a 2013 report by the Journal of the American Medical Association, 87 percent of patients initially triaged as non-urgent ended up with a diagnosis that constituted an emergency. Critics derided the scheme, citing that it was unlawful by federal law to cover a person based on diagnosis, not symptoms. It was also considered unsafe, as it pressured patients to diagnose themselves before going to the ER.

Neglecting complaints

In 2017, the California Department of Managed Health Care fined the company $5 million for untimely response to consumer complaints. In 2019, this was settled at $2.8 million.

2019 lawsuit for coercive direct payments

In 2019, Sovereign Health pressed charges against Anthem, alleging that it was using direct payments to compel them to join Anthem's network under unfavorable terms. Sovereign owns facilities that treat people with addiction and mental health problems.

Diagnostics fraud

In March 2020, Anthem was sued by the Department of Justice. The lawsuit alleges that Anthem had submitted inaccurate diagnostics data in order to obtain increased Medicare reimbursements. In October 2022, a judge ordered Anthem to face the lawsuit.

Medicare Advantage star rating

In January 2024, Elevance Health filed a lawsuit with the Department of Health and Human Services (HHS) challenging changes in the Medicare Advantage star rating methodology. Star ratings are tied to key bonus payouts, and due to the new rating system in 2024 ratings have significantly decreased.

Finances

For the fiscal year 2017, Anthem reported earnings of US$3.843 billion, with an annual revenue of US$90.039 billion, an increase of 6.1% over the previous fiscal cycle. Anthem's shares traded at over $183 per share, and its market capitalization was valued at over US$69.1 billion in October 2018.

Recognition

The company was featured on the S&P Dow Jones Sustainability Index from 2018 to 2022, was named by Fortune as one of the 100 Best Companies to Work For, and was included on the Corporate Equality Index's list of Best Places to Work for LGBTQ Equality from 2015 to 2022.

Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗

Wikidata ↗

ELV Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo
$400.48
Capitalizzazione di Mercato
$88.40B
P/E (TTM)
15.9
EPS (TTM)
$25.21
Ricavi (TTM)
$199.12B
Rendimento div.
1.7%
ROE
13.3%
D/E Debito/Patrimonio
0.7
Intervallo 52 sett.
$275 – $436

ELV Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $199.12B
10-point trend, +134.6%
2016-12-31 2025-12-31
EPS $25.21
10-point trend, +173.7%
2016-12-31 2025-12-31
Flusso di cassa libero $3.17B
10-point trend, +21.1%
2016-12-31 2025-12-31
Margini 2.8%

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica
Tendenza 5 anni
ELV
Mediana dei peer
P/E (TTM)
5-point trend, -25.2%
15.9
33.8
P/S (TTM)
5-point trend, -51.9%
0.4
0.7
P/B
5-point trend, -43.3%
2.0
3.2
EV / EBITDA
5-point trend, -22.9%
12.7
Price / FCF (Prezzo / FCF)
5-point trend, +58.3%
27.8

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica
Tendenza 5 anni
ELV
Mediana dei peer
Operating Margin (Margine Operativo)
5-point trend, -33.0%
3.6%
Net Profit Margin (Margine di Profitto Netto)
5-point trend, -35.5%
2.8%
0.82%
ROA
5-point trend, -28.4%
4.8%
2.2%
ROE
5-point trend, -21.8%
13.3%
6.2%
ROIC
5-point trend, -17.9%
8.0%

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica
Tendenza 5 anni
ELV
Mediana dei peer
Debt / Equity (Debito / Patrimonio Netto)
5-point trend, +14.3%
0.7
99.7
Current Ratio (Rapporto corrente)
5-point trend, +4.8%
1.5
1.6
Quick Ratio
5-point trend, +65.3%
0.2

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica
Tendenza 5 anni
ELV
Mediana dei peer
Revenue YoY (Ricavi YoY)
5-point trend, +43.6%
12.5%
Revenue CAGR 3Y (CAGR Ricavi 3Y)
5-point trend, +43.6%
8.3%
Revenue CAGR 5Y (CAGR Ricavi 5Y)
5-point trend, +43.6%
10.3%
EPS YoY
5-point trend, +1.0%
-1.8%
Net Income YoY (Utile Netto YoY)
5-point trend, -8.1%
-5.3%

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica
Tendenza 5 anni
ELV
Mediana dei peer
EPS (Diluted) (EPS (Diluito))
5-point trend, +1.0%
$25.21

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica
Tendenza 5 anni
ELV
Mediana dei peer
Payout Ratio (Rapporto di Distribuzione Utili)
5-point trend, +49.3%
27.0%

Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y

Dividend Yield
1.7%
Rapporto di Distribuzione Utili
27.0%
CAGR Dividendi 5Y
Data ex-dividendoImporto
10 Giugno 2026$1,7200
10 Marzo 2026$1,7200
05 Dicembre 2025$1,7100
10 Settembre 2025$1,7100
10 Giugno 2025$1,7100
10 Marzo 2025$1,7100
05 Dicembre 2024$1,6300
10 Settembre 2024$1,6300
10 Giugno 2024$1,6300
07 Marzo 2024$1,6300
05 Dicembre 2023$1,4800
07 Settembre 2023$1,4800
08 Giugno 2023$1,4800
09 Marzo 2023$1,4800
02 Dicembre 2022$1,2800
08 Settembre 2022$1,2800
09 Giugno 2022$1,2800
09 Marzo 2022$1,2800
02 Dicembre 2021$1,1300
09 Settembre 2021$1,1300

ELV Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

COMPRA 29 analisti
  • Acquisto forte 7 24,1%
  • Compra 12 41,4%
  • Mantieni 10 34,5%
  • Vendi 0 0,0%
  • Vendita forte 0 0,0%

Target Price a 12 Mesi

21 analisti · 2026-08-20
Target mediano $457.00 +14,1%
Target medio $449.10 +12,1%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media
0.72%
Periodo EPS Actual EPS Stimato Sorpresa
30 Giugno 2026 $7.45 $6.27 1.2%
31 Marzo 2026 $12.58 $10.93 1.6%
31 Dicembre 2025 $3.33 $3.13 0.20%
30 Settembre 2025 $6.03 $4.98 1.0%
30 Giugno 2025 $8.84 $9.04 -0.20%
31 Marzo 2025 $11.97 $11.50 0.47%

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Ticker Capitalizzazione di Mercato P/E Rev YoY Margine Netto ROE Margine lordo
ELV $77.37B 13.9 12.5% 2.8% 13.3%
UNH $299.08B 25.0 11.8% 2.7% 12.0%
HUM $50.90B 26.0 10.1% 0.92% 7.0%
CNC $20.24B -3.0 19.4% -3.4% -28.8% 7.3%
MOH $8.85B 19.5 11.8% 1.0% 10.9%
HQY $7.12B 34.0 9.5% 16.4% 10.1% 69.5%
ALHC $4.03B 46.1% -0.02% -0.52%
CLOV -5.1 40.3% -4.5% -26.2%
PGNY $2.14B 39.5 10.4% 4.5% 11.3% 23.6%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 13
Dati annuali Conto Economico per ELV
Metrica Tendenza 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +169.5% $199.12B $177.01B $171.34B $156.59B $138.64B $121.87B $104.21B $92.11B $90.04B $84.86B $79.16B $73.87B
Cost of Revenue 9-point trend, +21178000000.00 $21.18B $19.75B $17.29B $13.04B $10.89B $8.95B $1.99B $0 $0 · · ·
SG&A Expense 12-point trend, +78.6% $20.98B $20.02B $20.09B $17.70B $15.92B $17.45B $13.36B $14.02B $12.65B $12.56B $12.53B $11.75B
Operating Income 12-point trend, +62.9% $7.20B $7.86B $8.50B $8.28B $7.56B $6.36B $6.00B $5.43B $4.17B $4.80B $4.75B $4.42B
Interest Expense 10-point trend, +71.5% · · $1.03B $851M $798M $784M $746M $753M $739M $723M $653M $601M
Pretax Income 12-point trend, +53.6% $6.71B $7.90B $7.71B $7.60B $8.00B $6.24B $5.99B $5.07B $3.96B $4.55B $4.63B $4.37B
Income Tax 12-point trend, -42.0% $1.05B $1.93B $1.72B $1.71B $1.85B $1.67B $1.18B $1.32B $121M $2.08B $2.07B $1.81B
Net Income 12-point trend, +120.3% $5.66B $5.98B $5.99B $5.89B $6.16B $4.57B $4.81B $3.75B $3.84B $2.47B $2.56B $2.57B
EPS (Basic) 12-point trend, +171.5% $25.28 $25.81 $25.38 $24.56 $25.26 $18.23 $18.81 $14.53 $14.70 $9.39 $9.73 $9.31
EPS (Diluted) 12-point trend, +180.4% $25.21 $25.68 $25.22 $24.28 $24.95 $17.98 $18.47 $14.19 $14.35 $9.21 $9.38 $8.99
Shares (Basic) 12-point trend, -18.8% 224,000,000 231,700,000 235,900,000 240,000,000 243,800,000 250,800,000 255,500,000 258,100,000 261,500,000 262,900,000 263,000,000 275,900,000
Shares (Diluted) 12-point trend, -21.4% 224,600,000 232,900,000 237,400,000 242,800,000 246,800,000 254,300,000 260,300,000 264,200,000 267,800,000 268,100,000 272,900,000 285,900,000
EBITDA 12-point trend, +97.9% $8.74B $9.26B $10.24B $10.13B $8.79B $7.51B $6.00B $5.43B $4.18B $4.80B $4.75B $4.42B
Stato Patrimoniale 26
Dati annuali Stato Patrimoniale per ELV
Metrica Tendenza 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +341.1% $9.49B $8.29B $6.53B $7.39B $4.88B $5.74B $4.94B $3.93B $3.61B $4.08B $2.11B $2.15B
Other Current Assets 12-point trend, +262.6% $5.34B $4.70B $5.79B $5.28B $4.65B $4.06B $3.02B $2.10B $2.25B $1.78B $1.56B $1.47B
Current Assets 12-point trend, +97.2% $63.00B $58.94B $60.03B $55.62B $51.12B $45.75B $39.03B $34.32B $36.26B $34.31B $30.86B $31.95B
PP&E (Net) 12-point trend, +140.7% $4.68B $4.65B $4.36B $4.32B $3.92B $3.48B $3.13B $2.73B $2.17B $1.98B $2.02B $1.94B
PP&E (Gross) 12-point trend, +132.0% $8.73B $8.33B $7.90B $7.12B $8.26B $7.33B $6.48B $5.55B $4.37B $4.14B $4.06B $3.76B
Accum. Depreciation 12-point trend, +122.8% $4.06B $3.68B $3.54B $2.80B $4.34B $3.84B $3.35B $2.81B $2.20B $2.16B $2.04B $1.82B
Goodwill 12-point trend, +65.9% $28.34B $28.28B $25.32B $24.38B $24.23B $21.69B $20.50B $20.50B $19.23B $17.56B $17.56B $17.08B
Intangibles 12-point trend, +40.7% $11.20B $12.09B $10.27B $10.31B $10.62B $9.40B $8.67B $9.01B $8.37B $7.96B $8.16B $7.96B
Other Non-current Assets 12-point trend, +350.9% $2.31B $2.14B $1.97B $1.69B $1.72B $1.44B $1.35B $758M $565M $468M $485M $512M
Total Assets 12-point trend, +97.0% $121.49B $116.89B $108.93B $102.75B $97.46B $86.61B $77.45B $71.57B $70.54B $65.08B $61.72B $61.68B
Accounts Payable 12-point trend, +100.5% $7.32B $6.93B $6.91B $5.61B $4.97B $5.49B $4.20B $4.96B $5.02B $4.01B $3.32B $3.65B
Short-term Debt 12-point trend, -62.5% $150M $365M $225M $265M $275M $0 $700M $1.15B $1.27B $440M $540M $400M
Current Liabilities 12-point trend, +118.8% $41.03B $40.58B $41.79B $39.70B $34.88B $29.45B $23.53B $21.96B $23.36B $21.29B $19.09B $18.75B
Capital Leases 5-point trend, -38.8% $529M $658M $685M $751M $864M · · · · · · ·
Deferred Tax 12-point trend, -28.4% $2.11B $2.15B $1.97B $2.02B $2.81B $2.02B $2.23B $1.96B $1.73B $2.78B $2.63B $2.95B
Other Non-current Liabilities 12-point trend, +240.4% $3.53B $3.33B $1.74B $1.56B $1.68B $1.81B $1.42B $1.18B $925M $884M $994M $1.04B
Total Liabilities 12-point trend, +107.0% $77.47B $75.46B $69.52B $66.42B $61.29B $53.42B $45.73B $43.03B $44.04B $39.98B $38.67B $37.42B
Long-term Debt 12-point trend, +117.8% $31.90B $30.87B $24.89B $23.85B $22.76B $20.04B $19.39B $18.07B $18.66B $15.29B $15.32B $14.64B
Total Debt 12-point trend, +111.5% $32.05B $31.23B $25.12B $24.11B $23.03B $20.04B $20.09B $19.21B $19.93B $15.73B $15.86B $15.15B
Common Stock 12-point trend, -25.9% $2M $2M $2M $2M $2M $3M $3M $3M $3M $3M $3M $3M
Paid-in Capital 12-point trend, -11.2% $8.94B $8.91B $8.87B $9.08B $9.15B $9.24B $9.45B $9.54B $8.55B $8.81B $8.56B $10.06B
Retained Earnings 12-point trend, +152.5% $35.39B $33.55B $31.75B $29.65B $27.14B $23.80B $22.57B $19.99B $18.05B $16.56B $14.78B $14.01B
AOCI 12-point trend, -362.4% $-451M $-1.15B $-1.31B $-2.49B $-197M $150M $-296M $-986M $-101M $-268M $-293M $172M
Stockholders' Equity 12-point trend, +80.9% $43.88B $41.31B $39.31B $36.24B $36.09B $33.20B $31.73B $28.54B $26.50B $25.10B $23.05B $24.25B
Liabilities + Equity 12-point trend, +97.0% $121.49B $116.89B $108.93B $102.75B $97.46B $86.61B $77.45B $71.57B $70.54B $65.08B $61.72B $61.68B
Shares Outstanding 12-point trend, -17.7% 220,723,898 227,479,695 233,071,088 237,958,067 241,770,746 245,401,430 252,922,161 257,395,577 256,084,913 263,747,395 261,238,188 268,109,932
Flusso di cassa 18
Dati annuali Flusso di cassa per ELV
Metrica Tendenza 202520242023202220212020201920182017201620152014
D&A 8-point trend, +36.6% $1.55B $1.39B $1.75B $1.68B $1.30B $1.15B $1.13B $1.13B · · · ·
Stock-based Comp 12-point trend, +63.4% $276M $191M $289M $264M $255M $283M $294M $226M $170M $165M $148M $169M
Deferred Tax 12-point trend, -1008.8% $-279M $-374M $-602M $-115M $342M $-540M $81M $91M $-1.27B $127M $-66M $31M
Amort. of Intangibles 12-point trend, +184.3% $628M $580M $885M $767M $441M $361M $338M $358M $169M $192M $230M $221M
Other Non-cash 6-point trend, -155.9% $-2.92B $-1.38B $642M $511M $377M $5.22B · · · · · ·
Operating Cash Flow 12-point trend, +27.3% $4.29B $5.81B $8.06B $8.40B $8.36B $10.69B $6.06B $3.83B $4.18B $3.27B $4.21B $3.37B
CapEx 12-point trend, +56.2% $1.12B $1.26B $1.30B $1.15B $1.09B $1.02B $1.08B $1.21B $791M $584M $638M $715M
Investing Cash Flow 12-point trend, -37.9% $-1.34B $-5.17B $-5.57B $-4.56B $-9.64B $-7.32B $-2.79B $-1.26B $-5.08B $-514M $-1.15B $-975M
Debt Issued 12-point trend, +10.8% $2.99B $7.71B $2.57B $3.07B $3.46B $2.48B $2.47B $835M $5.46B $0 $1.23B $2.70B
Net Debt Issued 12-point trend, -13.0% $844M $6.06B $665M $1.17B $2.39B $552M $1.35B $-849M $2.64B $0 $-1.47B $970M
Stock Issued 5-point trend, +0.00 · · · · · $0 $0 $1.25B $0 $0 · ·
Stock Repurchased 12-point trend, -13.1% $2.60B $2.90B $2.68B $2.32B $1.90B $2.70B $1.70B $1.69B $2.00B $0 $1.52B $3.00B
Net Stock Activity 12-point trend, +13.1% $-2.60B $-2.90B $-2.68B $-2.32B $-1.90B $-2.70B $-1.70B $-435M $-2.00B $0 $-1.52B $-3.00B
Dividends Paid 12-point trend, +218.1% $1.53B $1.51B $1.40B $1.23B $1.10B $954M $818M $776M $705M $684M $657M $481M
Financing Cash Flow 12-point trend, +4.6% $-1.74B $1.19B $-3.35B $-1.32B $423M $-2.57B $-2.27B $-2.24B $427M $-799M $-3.09B $-1.82B
Net Change in Cash 12-point trend, +113.0% $1.20B $1.83B $-861M $2.51B $-861M $804M $1.00B $325M $-466M $1.96B $-38M $565M
Free Cash Flow 12-point trend, +19.6% $3.17B $4.55B $6.76B $7.25B $7.28B $9.67B $4.98B $2.62B $3.39B $2.62B $3.48B $2.65B
Levered FCF 10-point trend, +159.1% · · $5.97B $6.59B $6.66B $9.09B $4.38B $2.06B $2.67B $2.23B $3.12B $2.30B
Redditività 7
Dati annuali Redditività per ELV
Metrica Tendenza 202520242023202220212020201920182017201620152014
Operating Margin 12-point trend, -39.5% 3.6% 4.4% 5.0% 5.4% 5.4% 5.2% 5.8% 5.9% 4.6% 5.7% 6.0% 6.0%
Net Margin 12-point trend, -18.4% 2.8% 3.4% 3.5% 3.9% 4.4% 3.8% 4.6% 4.1% 4.3% 2.9% 3.2% 3.5%
Pretax Margin 12-point trend, -43.0% 3.4% 4.5% 4.5% 5.0% 5.7% 5.1% 5.7% 5.5% 4.4% 5.4% 5.9% 5.9%
EBITDA Margin 12-point trend, -26.6% 4.4% 5.2% 6.0% 6.5% 6.3% 6.2% 5.8% 5.9% 4.6% 5.7% 6.0% 6.0%
ROA 12-point trend, +12.3% 4.8% 5.3% 5.7% 6.0% 6.6% 5.6% 6.5% 5.3% 5.7% 3.9% 4.2% 4.2%
ROE 12-point trend, +25.5% 13.3% 14.8% 15.8% 16.7% 17.0% 13.6% 15.2% 13.0% 14.6% 9.9% 11.1% 10.6%
ROIC 12-point trend, +21.8% 8.0% 8.2% 10.2% 10.8% 9.8% 8.8% 9.3% 8.4% 8.7% 6.4% 6.8% 6.6%
Liquidità e Solvibilità 5
Dati annuali Liquidità e Solvibilità per ELV
Metrica Tendenza 202520242023202220212020201920182017201620152014
Current Ratio 12-point trend, -10.7% 1.5 1.5 1.4 1.4 1.5 1.6 1.7 1.6 1.6 1.6 1.6 1.7
Quick Ratio 12-point trend, +101.7% 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.1 0.1
Debt / Equity 12-point trend, +16.9% 0.7 0.8 0.6 0.7 0.6 0.6 0.6 0.7 0.8 0.6 0.7 0.6
LT Debt / Equity 12-point trend, +20.5% 0.7 0.7 0.6 0.6 0.6 0.6 0.6 0.6 0.7 0.6 0.7 0.6
Interest Coverage 10-point trend, +12.2% · · 8.3 9.9 9.4 8.1 8.0 7.2 5.7 6.6 7.3 7.4
Efficienza 1
Dati annuali Efficienza per ELV
Metrica Tendenza 202520242023202220212020201920182017201620152014
Asset Turnover 12-point trend, +37.5% 1.7 1.6 1.6 1.6 1.5 1.5 1.4 1.3 1.3 1.3 1.3 1.2
Per Azione 6
Dati annuali Per Azione per ELV
Metrica Tendenza 202520242023202220212020201920182017201620152014
Book Value / Share 12-point trend, +119.8% $198.81 $181.62 $168.64 $152.58 $149.15 $135.28 $125.45 $110.88 $103.49 $95.17 $88.21 $90.45
Revenue / Share 12-point trend, +243.1% $886.58 $760.03 $721.74 $644.95 $561.75 $479.23 $400.36 $348.62 $336.22 $316.53 $290.06 $258.39
Cash Flow / Share 12-point trend, +62.1% $19.10 $24.94 $33.96 $34.59 $33.89 $42.03 $23.28 $14.49 $15.63 $11.95 $15.08 $11.78
Cash / Share 12-point trend, +435.8% $43.00 $36.43 $28.00 $31.04 $20.18 $23.39 $19.52 $15.28 $14.09 $15.45 $8.09 $8.03
Dividend / Share 10-point trend, +238.3% · · $6 $5 $5 $4 $3 $3 $3 $3 $2 $2
EPS (TTM) 12-point trend, +180.4% $25.21 $25.68 $25.22 $24.28 $24.95 $17.98 $18.47 $14.19 $14.35 $9.21 $9.38 $8.99
Tassi di Crescita 10
Dati annuali Tassi di Crescita per ELV
Metrica Tendenza 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -9.2% 12.5% 3.3% 9.4% 13.0% 13.8% · · · · · · ·
Revenue CAGR 3Y 3-point trend, -30.7% 8.3% 8.5% 12.0% · · · · · · · · ·
Revenue CAGR 5Y 10.3% · · · · · · · · · · ·
EPS YoY 5-point trend, -104.7% -1.8% 1.8% 3.9% -2.7% 38.8% · · · · · · ·
EPS CAGR 3Y 3-point trend, -89.4% 1.3% 0.97% 11.9% · · · · · · · · ·
EPS CAGR 5Y 7.0% · · · · · · · · · · ·
Net Income YoY 5-point trend, -115.3% -5.3% -0.12% 1.6% -4.3% 34.7% · · · · · · ·
Net Income CAGR 3Y 3-point trend, -114.1% -1.3% -0.97% 9.4% · · · · · · · · ·
Net Income CAGR 5Y 4.4% · · · · · · · · · · ·
Dividend CAGR 5Y 9.9% · · · · · · · · · · ·
Valutazione (TTM) 17
Dati annuali Valutazione (TTM) per ELV
Metrica Tendenza 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +169.5% $199.12B $177.01B $171.34B $156.59B $138.64B $121.87B $104.21B $92.11B $90.04B $84.86B $79.16B $73.87B
Net Income TTM 12-point trend, +120.3% $5.66B $5.98B $5.99B $5.89B $6.16B $4.57B $4.81B $3.75B $3.84B $2.47B $2.56B $2.57B
Market Cap 12-point trend, +129.6% $77.37B $83.92B $109.91B $122.07B $112.07B $78.80B $76.39B $67.60B $57.62B $37.92B $36.43B $33.69B
Enterprise Value 12-point trend, +114.0% $99.93B $106.86B $128.50B $138.79B $130.22B $93.09B $91.54B $82.88B $73.94B $49.57B $50.18B $46.69B
P/E 12-point trend, -0.5% 13.9 14.4 18.7 21.1 18.6 17.9 16.4 18.5 15.7 15.6 14.9 14.0
P/S 12-point trend, -14.8% 0.4 0.5 0.6 0.8 0.8 0.6 0.7 0.7 0.6 0.4 0.5 0.5
P/B 12-point trend, +26.9% 1.8 2.0 2.8 3.4 3.1 2.4 2.4 2.4 2.2 1.5 1.6 1.4
P / Tangible Book 6-point trend, -52.4% 17.8 88.9 29.6 79.0 89.5 37.5 · · · · · ·
P / Cash Flow 12-point trend, +80.4% 18.0 14.4 13.6 14.5 13.4 7.4 12.6 17.7 13.8 11.8 8.9 10.0
P / FCF 12-point trend, +92.1% 24.4 18.4 16.2 16.8 15.4 8.2 15.3 25.8 17.0 14.5 10.5 12.7
EV / EBITDA 12-point trend, +8.1% 11.4 11.5 12.5 13.7 14.8 12.4 15.3 15.3 17.7 10.3 10.6 10.6
EV / FCF 12-point trend, +79.0% 31.5 23.5 19.0 19.2 17.9 9.6 18.4 31.6 21.8 18.9 14.4 17.6
EV / Revenue 12-point trend, -20.6% 0.5 0.6 0.8 0.9 0.9 0.8 0.9 0.9 0.8 0.6 0.6 0.6
Dividend Yield 12-point trend, +38.5% 2.0% 1.8% 1.3% 1.0% 0.99% 1.2% 1.1% 1.1% 1.2% 1.8% 1.8% 1.4%
Earnings Yield 12-point trend, +0.6% 7.2% 7.0% 5.3% 4.7% 5.4% 5.6% 6.1% 5.4% 6.4% 6.4% 6.7% 7.1%
Payout Ratio 12-point trend, +44.3% 27.0% 25.2% 23.3% 20.4% 18.1% 20.9% 17.0% 20.7% 18.3% 27.7% 25.7% 18.7%
Annual Payout 12-point trend, +218.1% $1.53B $1.51B $1.40B $1.23B $1.10B $954M $818M $776M $705M $684M $657M $481M

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico
2025-12-312024-12-312023-12-312022-12-312021-12-31
Ricavi $199.12B$177.01B$171.34B$156.59B$138.64B
Margine Operativo % 3.6%4.4%5.0%5.4%5.4%
Utile netto $5.66B$5.98B$5.99B$5.89B$6.16B
EPS Diluito $25.21$25.68$25.22$24.28$24.95
Stato Patrimoniale
2025-12-312024-12-312023-12-312022-12-312021-12-31
Debito / Patrimonio Netto 0.70.80.60.70.6
Rapporto corrente 1.51.51.41.41.5
Quick Ratio 0.20.20.20.20.1
Flusso di cassa
2025-12-312024-12-312023-12-312022-12-312021-12-31
Flusso di cassa libero $3.17B$4.55B$6.76B$7.25B$7.28B

Ultime notizie Notizie recenti che menzionano questa società

Segnali di trading Segnali recenti di acquisto/vendita con prezzo di entrata e rapporto rischio/rendimento

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Proprietari istituzionali (13F) 1.772 filer · $54.8B totale · Aggiornato al 30 Giugno 2026

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Attività istituzionale — Q2 2026 vs trimestre precedente
Nuove posizioni Posizioni chiuse Aumentato Diminuito Variazione netta delle azioni
271 (+102 vs trimestre precedente) 94 (-108 vs trimestre precedente) 588 (+107 vs trimestre precedente) 531 (-112 vs trimestre precedente) +7.8M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione Valore Azioni % di 13F tracciati Tipo
VANGUARD GROUP INC $7.274.315.633 20.751.150 13,26% Azioni
VANGUARD CAPITAL MANAGEMENT LLC $5.436.729.233 14.058.204 9,91% Azioni
STATE STREET CORP $4.032.282.885 10.426.610 7,35% Azioni
WELLINGTON MANAGEMENT GROUP LLP $3.179.014.962 8.220.244 5,80% Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC $2.403.277.896 6.214.356 4,38% Azioni
Sanders Capital, LLC $2.252.711.532 5.825.024 4,11% Azioni
Artisan Partners Limited Partnership $1.771.695.984 4.581.222 3,23% Azioni
GEODE CAPITAL MANAGEMENT, LLC $1.712.764.692 4.448.634 3,12% Azioni
NORGES BANK $1.531.008.381 3.958.856 2,79% Azioni
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC $779.725.026 2.016.200 1,42% Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $697.513.963 1.803.620 1,27% Azioni
Grantham, Mayo, Van Otterloo & Co. LLC $654.221.093 1.691.671 1,19% Azioni
FMR LLC $633.317.160 1.637.621 1,15% Azioni
MANUFACTURERS LIFE INSURANCE COMPANY, THE $591.084.393 1.528.416 1,08% Azioni
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $588.871.451 1.522.694 1,07% Azioni
EAGLE CAPITAL MANAGEMENT LLC $576.772.638 1.491.409 1,05% Azioni
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $511.706.827 1.323.163 0,93% Azioni
DIMENSIONAL FUND ADVISORS LP $511.575.693 1.322.824 0,93% Azioni
VANGUARD FIDUCIARY TRUST CO $461.498.831 1.193.336 0,84% Azioni
Ruane, Cunniff & Goldfarb L.P. $378.839.935 979.598 0,69% Azioni
Brave Warrior Advisors, LLC $377.790.736 976.885 0,69% Azioni
Newport Trust Company, LLC $369.294.278 954.915 0,67% Azioni
1832 Asset Management L.P. $355.109.795 918.237 0,65% Azioni
CITADEL ADVISORS LLC $293.751.600 759.578 0,54% Azioni
Capital International Investors $290.732.899 751.772 0,53% Azioni
MILLENNIUM MANAGEMENT LLC $281.369.666 727.561 0,51% Azioni
BlackRock, Inc. $268.353.881 693.905 0,49% Azioni
High Ground Investment Management LLP $262.939.273 679.904 0,48% Azioni
CANADA PENSION PLAN INVESTMENT BOARD $261.530.030 676.260 0,48% Azioni
Legal & General Group Plc $259.012.033 669.749 0,47% Azioni
ACR Alpine Capital Research, LLC $254.804.222 658.869 0,46% Azioni
Qube Research & Technologies Ltd $247.577.198 640.181 0,45% Azioni
VICTORY CAPITAL MANAGEMENT INC $240.259.106 621.258 0,44% Azioni
Swiss National Bank $239.610.173 619.580 0,44% Azioni
CAPITOLIS LIQUID GLOBAL MARKETS LLC $237.525.699 614.190 0,43% Azioni
National Pension Service $228.059.708 589.713 0,42% Azioni
GOLDMAN SACHS GROUP INC $222.913.559 576.406 0,41% Azioni
Sumitomo Mitsui Trust Group, Inc. $220.953.931 571.339 0,40% Azioni
Mitsubishi UFJ Asset Management Co., Ltd. $205.911.600 532.437 0,38% Azioni
Ninety One UK Ltd $196.567.097 508.280 0,36% Azioni
ALLIANCEBERNSTEIN L.P. $191.531.395 654.249 0,35% Azioni
FIRST TRUST ADVISORS LP $189.503.803 490.016 0,35% Azioni
Vanguard Global Advisers, LLC $183.654.210 474.890 0,33% Azioni
ENVESTNET ASSET MANAGEMENT INC $181.045.755 468.145 0,33% Azioni
8 KNOTS MANAGEMENT, LLC $179.336.122 511.585 0,33% Azioni
Focused Investors LLC $178.514.568 461.600 0,33% Azioni
Nuveen Asset Management, LLC $171.198.670 464.079 0,31% Azioni
DAVENPORT & Co LLC $171.104.235 441.940 0,31% Azioni
VANGUARD ASSET MANAGEMENT, Ltd $167.143.159 432.196 0,30% Azioni
Veritas Asset Management LLP $165.780.323 428.672 0,30% Azioni
RHUMBLINE ADVISERS $161.791.876 418.359 0,29% Azioni
California Public Employees Retirement System $157.606.784 407.537 0,29% Azioni
FIL Ltd $157.293.146 406.726 0,29% Azioni
MANNING & NAPIER ADVISORS LLC $142.522.435 367.297 0,26% Azioni
Canoe Financial LP $140.577.902 363.504 0,26% Azioni
YACKTMAN ASSET MANAGEMENT LP $131.482.399 339.985 0,24% Azioni
BANK OF AMERICA CORP /DE/ $121.697.356 314.683 0,22% Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP $121.433.220 314.000 0,22% Opzione Put
AMERIPRISE FINANCIAL INC $119.565.700 309.171 0,22% Azioni
Swedbank AB $116.986.211 302.501 0,21% Azioni
Assenagon Asset Management S.A. $115.776.907 299.374 0,21% Azioni
M&G PLC $114.210.666 295.118 0,21% Azioni
Quantinno Capital Management LP $112.935.724 292.027 0,21% Azioni
Universal- Beteiligungs- und Servicegesellschaft mbH $112.933.654 282.040 0,21% Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP $107.897.670 279.000 0,20% Opzione Call
BANK OF NOVA SCOTIA $101.450.881 262.330 0,18% Azioni
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $96.843.749 330.807 0,18% Azioni
Diamond Hill Capital Management, LLC (Investment Advisor) $96.574.989 249.722 0,18% Azioni
Caisse de depot et placement du Quebec $94.418.969 244.147 0,17% Azioni
Sound Shore Management Inc /CT/ $94.150.192 243.452 0,17% Azioni
NEW YORK STATE COMMON RETIREMENT FUND $93.705.452 242.302 0,17% Azioni
AMF Tjanstepension AB $92.093.175 238.133 0,17% Azioni
BNP PARIBAS FINANCIAL MARKETS $91.136.405 235.659 0,17% Azioni
MACKENZIE FINANCIAL CORP $90.587.635 234.240 0,17% Azioni
ROYAL LONDON ASSET MANAGEMENT LTD $89.603.021 231.694 0,16% Azioni
JANE STREET GROUP, LLC $87.130.269 225.300 0,16% Opzione Call
PZENA INVESTMENT MANAGEMENT LLC $86.849.890 224.575 0,16% Azioni
Marathon Asset Management Ltd $84.882.114 219.490 0,15% Azioni
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $84.674.534 218.950 0,15% Azioni
BARCLAYS PLC $79.161.697 204.695 0,14% Azioni
RENAISSANCE TECHNOLOGIES LLC $77.876.980 201.373 0,14% Azioni
CITADEL ADVISORS LLC $77.152.635 199.500 0,14% Opzione Put
AVIVA PLC $77.089.211 199.336 0,14% Azioni
TD Asset Management Inc $75.328.430 194.783 0,14% Azioni
Maple Rock Capital Partners Inc. $74.058.795 191.500 0,14% Azioni
Mawer Investment Management Ltd. $72.431.822 187.293 0,13% Azioni
Freestone Grove Partners LP $72.096.914 186.427 0,13% Azioni
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $71.577.149 185.083 0,13% Azioni
Zurcher Kantonalbank (Zurich Cantonalbank) $71.371.408 184.551 0,13% Azioni
Orbis Allan Gray Ltd $70.845.455 183.191 0,13% Azioni
Jefferies Financial Group Inc. $69.850.785 180.619 0,13% Azioni
CITADEL ADVISORS LLC $69.069.978 178.600 0,13% Opzione Call
Korea Investment CORP $68.952.025 178.295 0,13% Azioni
Harvest Portfolios Group Inc. $68.795.400 177.890 0,13% Azioni
RAYMOND JAMES FINANCIAL INC $68.556.341 177.272 0,13% Azioni
LPL Financial LLC $67.831.262 175.397 0,12% Azioni
Alyeska Investment Group, L.P. $67.228.756 173.839 0,12% Azioni
Robeco Institutional Asset Management B.V. $66.324.193 171.500 0,12% Azioni
APG Asset Management N.V. $66.031.619 195.211 0,12% Azioni
ADAGE CAPITAL PARTNERS GP, L.L.C. $66.009.784 170.687 0,12% Azioni

Insider aziendali 92 insider · 55 dirigenti · 36 direttori

Insider Ruolo Ultima attività Azioni possedute Acquisti 12m Vendite 12m Netto 12m
Gail Boudreaux President and CEO 17 Luglio 2026 P 171.976 2 0 $1.002.230
Brian T Griffin EVP & CEO, IngenioRx 03 Maggio 2018 M 15.863 0 0 $0
Angela F Braly Chair, President & CEO 01 Marzo 2012 A 476.503 0 0 $0
Brian A Sassi President & CEO Cons, EVP 07 Giugno 2011 S 60.825 0 0 $0
Dijuana K Lewis Pres & CEO CHS and EVP 20 Maggio 2010 M 44.107 0 0 $0
Mark L Boxer Pres & CEO of OT&GS and EVP 04 Aprile 2008 F 42.143 0 0 $0
Joan E Herman President & CEO Cons and EVP 07 Dicembre 2007 S 30.369 0 0 $0
Mark Kaye EVP & CFO 24 Aprile 2025 S 18.977 0 0 $0
John E Gallina EVP & Chief Financial Officer 01 Marzo 2023 A 63.725 0 0 $0
Wayne S Deveydt EVP & Chief Financial Officer 03 Marzo 2016 F 57.957 0 0 $0
David C Colby Vice Chairman, CFO & EVP 04 Aprile 2007 F 343.071 0 0 $0
Thomas R Byrd President, Anthem Specialty 26 Novembre 2004 A 26.580 0 0 $0
Michael D Houk President, National Accounts 04 Novembre 2004 M 18.843 0 0 $0
John M Murphy President, Specialty Business 17 Maggio 2004 A 20.806 0 0 $0
Caroline S Matthews Chief Operating Officer 01 Dicembre 2004 A 40.471 0 0 $0
Ronald W Penczek CAO & Controller 12 Giugno 2026 S 3.740 0 1 $-148.766
Charles Morgan Kendrick JR EVP & President, Commercial 03 Marzo 2025 A 10.116 0 0 $0
Felicia F Norwood EVP & President,Gov Health Ben 03 Marzo 2025 A 31.939 0 0 $0
Ratnakar Lavu EVP, Chief Digital & Info Off 03 Marzo 2025 A 4.783 0 0 $0
Peter D Haytaian EVP & Pres Carelon & CarelonRx 03 Marzo 2025 A 26.004 0 0 $0
Blair Williams Todt EVP, CLO & CAO 03 Gennaio 2025 F 15.631 0 0 $0
Gloria M Mccarthy EVP & Chief Administrative Off 24 Marzo 2023 S 51.435 0 0 $0
Leah Stark EVP & CHRO 30 Dicembre 2021 F 12.403 0 0 $0
Jeffrey D. Alter EVP, IngenioRx & Anthem Health 01 Ottobre 2021 F 5.107 0 0 $0
Patel Prakash R EVP & President, DBG 04 Settembre 2021 F 17.230 0 0 $0
Thomas C Zielinski EVP & General Counsel 03 Novembre 2020 M 17.910 0 0 $0
Craig E Samitt EVP & President, DBG 26 Luglio 2018 M 17.274 0 0 $0
Joseph Swedish Executive Chairman 05 Marzo 2018 S 61.419 0 0 $0
Jacquelyn H Wolf EVP & Chief HR Officer 01 Marzo 2018 A 3.105 0 0 $0
Jose D. Tomas EVP & Chief HR Officer 03 Marzo 2017 F 23.927 0 0 $0
Samuel R Nussbaum MD EVP & Chief Medical Officer 19 Maggio 2015 M 110.973 0 0 $0
Martin B Silverstein EVP & Chief Strategy Officer 01 Maggio 2015 F 23.249 0 0 $0
Kenneth R Goulet EVP, Commercial & Specialty 02 Marzo 2015 A 84.281 0 0 $0
Richard C Zoretic EVP, Gov Business Division 03 Marzo 2014 A 53.572 0 0 $0
John Cannon EVP, GC & Chief PAO 13 Dicembre 2013 S 99.331 0 0 $0
Randal L Brown EVP & Chief HR Officer 04 Settembre 2013 M 30.332 0 0 $0
Lori A Beer EVP, Specialty Businesses & IT 30 Maggio 2013 M 113.955 0 0 $0
Harlan A Levine EVP, CHS 31 Agosto 2012 S 25.244 0 0 $0
Venkata R Madabhushi EVP Sr Bus & Chf Transfrmn Off 02 Aprile 2012 A 45.237 0 0 $0
Miller Martin SVP & Chief Accounting Officer 01 Marzo 2011 A 29.329 0 0 $0
Fluegel M Bradley EVP, Chief Strategy Officer 05 Novembre 2010 M 52.634 0 0 $0
Cynthia S Miller EVP & Chief Actuary 01 Marzo 2010 A 60.757 0 0 $0
Randall J Lewis EVP & Chief Compliance Officer 07 Agosto 2009 M 13.658 0 0 $0
Jamie S Miller SVP & Chief Accounting Officer 03 Marzo 2008 A 25.710 0 0 $0
Alice F Rosenblatt EVP and Chief Actuary 22 Gennaio 2008 S 39.265 0 0 $0
John S Watts JR EVP 07 Dicembre 2007 S 108.311 0 0 $0
Marjorie W Dorr EVP 22 Maggio 2007 M 38.951 0 0 $0
Michael A Stocker EVP 23 Ottobre 2006 M 42.186 0 0 $0
Keith R Faller EVP 12 Settembre 2006 M 83.290 0 0 $0
David S Helwig EVP 18 Agosto 2006 M 55.055 0 0 $0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 212 ETF

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo Peso Unità Aggiornato al Fonte
GFGF · EA Series Trust 3,75% 3.541 NS 29 Maggio 2026 N-PORT
MDPL · Northern Lights Fund Trust IV 3,24% 5.013 NS 31 Maggio 2026 N-PORT
FXH · First Trust Exchange-Traded AlphaDE… 2,78% 64.637 NS 30 Aprile 2026 N-PORT
ABCS · EA Series Trust 2,29% 661 NS 29 Maggio 2026 N-PORT
FEGE · RBB Fund Trust 1,92% 94.302 NS 31 Maggio 2026 N-PORT
QLTY · GMO ETF Trust 1,75% 200.065 NS 31 Maggio 2026 N-PORT
TOLL · Tema ETF Trust 1,71% 2.139 NS 31 Maggio 2026 N-PORT
SRHQ · Elevation Series Trust 1,54% 7.891 NS 30 Aprile 2026 N-PORT
BKDV · BNY Mellon ETF Trust II 1,52% 55.921 NS 30 Aprile 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 1,35% 102.444 NS 30 Aprile 2026 N-PORT
RXL · ProShares Trust 1,26% 2.301 NS 31 Maggio 2026 N-PORT
VMAX · Lattice Strategies Trust 1,25% 1.543 NS 30 Aprile 2026 N-PORT
CURE · Direxion Shares ETF Trust 1,20% 4.402 NS 30 Aprile 2026 N-PORT
FTA · First Trust Exchange-Traded AlphaDE… 1,12% 38.663 NS 30 Aprile 2026 N-PORT
NUDV · Nushares ETF Trust 1,09% 1.312 NS 30 Aprile 2026 N-PORT
AVIE · AMERICAN CENTURY ETF TRUST 1,06% 278 NS 31 Maggio 2026 N-PORT
MFSV · MFS Active Exchange Traded Funds Tr… 1,04% 12.508 NS 31 Maggio 2026 N-PORT
PY · Principal Exchange-Traded Funds 1,04% 5.907 NS 30 Giugno 2026 N-PORT
RDVI · First Trust Exchange-Traded Fund IV 0,96% 78.591 NS 30 Aprile 2026 N-PORT
PALC · Pacer Funds Trust 0,96% 5.883 NS 30 Aprile 2026 N-PORT
GMOV · GMO ETF Trust 0,93% 2.152 NS 31 Maggio 2026 N-PORT
EQIN · Columbia ETF Trust I 0,90% 6.636 NS 30 Aprile 2026 N-PORT
ROUS · Lattice Strategies Trust 0,77% 12.014 NS 30 Aprile 2026 N-PORT
NULC · Nushares ETF Trust 0,73% 1.105 NS 30 Aprile 2026 N-PORT
FEUS · FlexShares Trust 0,64% 1.881 NS 30 Aprile 2026 N-PORT
FDLO · FIDELITY COVINGTON TRUST 0,62% 23.028 NS 30 Aprile 2026 N-PORT
COPY · RBB Fund Trust 0,60% 5.260 NS 31 Maggio 2026 N-PORT
FBCV · FIDELITY COVINGTON TRUST 0,60% 2.551 NS 30 Aprile 2026 N-PORT
FAB · First Trust Exchange-Traded AlphaDE… 0,55% 2.039 NS 30 Aprile 2026 N-PORT
FEX · First Trust Exchange-Traded AlphaDE… 0,53% 20.983 NS 30 Aprile 2026 N-PORT
FNDX · SCHWAB STRATEGIC TRUST 0,51% 327.388 NS 31 Maggio 2026 N-PORT
FNDB · SCHWAB STRATEGIC TRUST 0,46% 15.433 NS 31 Maggio 2026 N-PORT
QUVU · Hartford Funds Exchange-Traded Trust 0,44% 2.019 NS 30 Aprile 2026 N-PORT
DFLV · Dimensional ETF Trust 0,42% 65.620 NS 30 Aprile 2026 N-PORT
DFUV · Dimensional ETF Trust 0,41% 155.796 NS 30 Aprile 2026 N-PORT
JVAL · J.P. Morgan Exchange-Traded Fund Tr… 0,40% 7.882 NS 30 Aprile 2026 N-PORT
SPXD · DBX ETF Trust 0,34% 59 NS 31 Maggio 2026 N-PORT
HDUS · Lattice Strategies Trust 0,31% 1.498 NS 30 Aprile 2026 N-PORT
ESG · FlexShares Trust 0,31% 1.054 NS 30 Aprile 2026 N-PORT
ACIO · ETF Series Solutions 0,29% 17.793 NS 30 Aprile 2026 N-PORT
ADME · ETF Series Solutions 0,29% 2.062 NS 30 Aprile 2026 N-PORT
SCHV · SCHWAB STRATEGIC TRUST 0,28% 111.273 NS 31 Maggio 2026 N-PORT
GVUS · Goldman Sachs ETF Trust 0,26% 2.725 NS 31 Maggio 2026 N-PORT
IQSU · New York Life Investments ETF Trust 0,26% 2.144 NS 30 Aprile 2026 N-PORT
FBUF · Fidelity Greenwood Street Trust 0,25% 127 NS 30 Aprile 2026 N-PORT
USSG · DBX ETF Trust 0,25% 3.671 NS 29 Maggio 2026 N-PORT
ESGG · FlexShares Trust 0,25% 720 NS 30 Aprile 2026 N-PORT
JPUS · J.P. Morgan Exchange-Traded Fund Tr… 0,24% 2.806 NS 30 Aprile 2026 N-PORT
DFSU · Dimensional ETF Trust 0,22% 12.245 NS 30 Aprile 2026 N-PORT
SNPE · DBX ETF Trust 0,22% 15.245 NS 29 Maggio 2026 N-PORT